NFYB9 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
NFYB9 antibody; LEC1 antibody; At1g21970 antibody; T26F17.20 antibody; Nuclear transcription factor Y subunit B-9 antibody; AtNF-YB-9 antibody; Protein LEAFY COTYLEDON 1 antibody
Target Names
NFYB9
Uniprot No.

Target Background

Function

The NFYB9 protein is a component of the NF-Y/HAP transcription factor complex. This complex plays a crucial role in gene transcription by binding to CCAAT motifs within gene promoters. NFYB9 is a central regulator of embryogenesis, essential for cotyledon identity specification and the completion of embryo maturation. It regulates seed storage protein genes via the control of FUS3 and ABI3, and participates in blue light (BL) and abscisic acid (ABA) signaling pathways.

Gene References Into Functions

Further research highlights key functions of NFYB9 and related factors:

  • Protein Interactions: Mutations in key amino acids of LEC1 (a related factor) prevent interaction with LEC2, demonstrating the importance of heteromer formation for gene expression regulation (PMID: 29580949).
  • Developmental Regulation: LEC1 controls distinct gene sets at various developmental stages, influencing the transition between photosynthesis and chloroplast biogenesis (PMID: 28739919).
  • Epigenetic Control: LEC1 establishes an active chromatin state at FLC, activating its expression and transmitting this activation to post-embryonic stages (PMID: 29072296).
  • Promoter Activity: Nuclear Factor Y (NF-Y) binds to a CCAAT box in the FT promoter, and disruption of this binding significantly reduces promoter activity (PMID: 24610724).
  • Repression Mechanisms: Epigenetic mechanisms maintain repression of the LEC1/AFL network during vegetative development (PMID: 24902838).
  • Embryonic Development: LEC1 regulates somatic embryogenesis and influences both embryonic and extra-embryonic cell elongation (PMID: 23073004).
  • ABA Signaling: NF-Y transcription factors exhibit both opposing and additive roles in ABA-mediated seed germination (PMID: 23527203).
  • Regulatory Integration: LEC1 integrates various regulatory events, including transcription factor activity and light and hormone signaling, especially during early embryogenesis (PMID: 22429691).
  • Somatic Embryogenesis: LEC mutants exhibit reduced somatic embryo formation (PMID: 16034595).
  • Transcriptional Network: LEC1 participates in a complex network regulating gene expression (PMID: 17158584).
  • Metabolic Regulation: LEC1 positively regulates fatty acid biosynthesis genes and influences glycolysis and lipid accumulation (PMID: 18689444).
  • Promoter Activation: LEC1 and LEC1-LIKE activate the CRC and SUS2 promoters in combination with NF-YC and bZIP67 (PMID: 19207209).
Database Links

KEGG: ath:AT1G21970

STRING: 3702.AT1G21970.1

UniGene: At.28011

Protein Families
NFYB/HAP3 subunit family
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in green siliques. Present in etiolated seedlings.

Q&A

What is NFYB9 and what is its role in Arabidopsis thaliana?

NFYB9 (Nuclear Factor Y, subunit B9) is a transcription factor that belongs to the NF-Y complex family in Arabidopsis thaliana. This protein functions as part of a heterotrimeric complex that binds to CCAAT motifs in promoter regions to regulate gene expression. NFYB9 plays critical roles in developmental processes, stress responses, and flowering time regulation. The protein contains a highly conserved histone-fold domain that facilitates DNA binding and protein-protein interactions with other NF-Y subunits (A and C types).

When studying NFYB9, it's important to understand its structural similarity to other NFYB family members in Arabidopsis, as this can affect antibody specificity. The NFYB family in Arabidopsis includes multiple members (NFYB1-NFYB11) with varying degrees of sequence homology, making selective detection challenging but essential for accurate research outcomes.

How do I verify the specificity of NFYB9 antibodies for experimental applications?

Methodological approach for validating NFYB9 antibody specificity:

  • Western blot analysis using:

    • Wild-type Arabidopsis protein extracts (positive control)

    • NFYB9 knockout/knockdown mutant extracts (negative control)

    • Recombinant NFYB9 protein (specificity reference)

  • Cross-reactivity assessment:

    • Test against purified recombinant proteins of related NFYB family members (NFYB7, etc.)

    • Perform peptide competition assays using the specific peptide antigen used for immunization

  • Immunoprecipitation validation:

    • Perform IP followed by mass spectrometry to confirm antibody captures NFYB9

    • Verify co-immunoprecipitation of known NFYB9 interaction partners (NFYA/NFYC subunits)

The specificity validation should demonstrate a single band at the expected molecular weight (~23 kDa) for NFYB9, minimal cross-reactivity with other NFYB proteins, and absence or significant reduction of signal in NFYB9 knockout lines. This multi-approach validation is essential given the high sequence similarity among NFYB family members.

What are the optimal protocols for using NFYB9 antibody in immunoblotting experiments?

For optimal NFYB9 antibody performance in Western blotting, follow this methodology:

  • Sample preparation:

    • Extract total protein from Arabidopsis tissues using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, and protease inhibitor cocktail

    • Include 10 mM DTT to ensure reduction of disulfide bonds

    • Heat samples at 95°C for 5 minutes in Laemmli buffer

  • Gel electrophoresis and transfer:

    • Use 12-15% SDS-PAGE to achieve optimal separation around the 23 kDa region

    • Transfer to PVDF membrane (0.45 μm) using semi-dry transfer at 15V for 30 minutes

  • Blocking and antibody incubation:

    • Block with 5% non-fat dry milk in TBS-T (0.1% Tween-20) for 1 hour at room temperature

    • Incubate with NFYB9 primary antibody at 1:1000 dilution overnight at 4°C

    • Wash 3 times with TBS-T, 10 minutes each

    • Incubate with HRP-conjugated secondary antibody at 1:5000 for 1 hour at room temperature

  • Detection optimization:

    • Use enhanced chemiluminescence (ECL) detection with 1-minute exposure

    • For low abundance detection, consider using super-signal ECL substrates or fluorescent secondary antibodies

This protocol has been optimized to minimize background and maximize signal specificity, which is particularly important when working with transcription factors that may be present at relatively low abundance in total protein extracts.

How can I effectively use NFYB9 antibody in chromatin immunoprecipitation (ChIP) assays?

Methodological framework for NFYB9 ChIP:

  • Crosslinking and chromatin preparation:

    • Harvest 3-5g of Arabidopsis tissue and crosslink with 1% formaldehyde for 10 minutes under vacuum

    • Quench with 0.125M glycine for 5 minutes

    • Extract nuclei using Honda buffer (0.44M sucrose, 1.25% Ficoll, etc.)

    • Sonicate chromatin to 200-500bp fragments (optimized conditions: 30 seconds on/30 seconds off, 10 cycles)

  • Immunoprecipitation:

    • Pre-clear chromatin with Protein A/G beads for 1 hour at 4°C

    • Incubate 10-15 μg of chromatin with 2-5 μg NFYB9 antibody overnight at 4°C

    • Include IgG control and input samples (10% of immunoprecipitated material)

    • Capture antibody-chromatin complexes with Protein A/G beads for 3 hours at 4°C

  • Washing and elution:

    • Wash complexes with increasing stringency buffers (low salt, high salt, LiCl, TE)

    • Elute DNA-protein complexes with elution buffer (1% SDS, 0.1M NaHCO₃)

    • Reverse crosslinks at 65°C overnight

    • Treat with RNase A and Proteinase K

    • Purify DNA using phenol-chloroform extraction or column purification

  • Analysis:

    • Perform qPCR on known CCAAT-containing promoters

    • For genome-wide studies, prepare libraries for ChIP-seq using 5-10 ng of immunoprecipitated DNA

This methodology has been optimized for transcription factors with the histone-fold domain characteristic of NF-Y family members, which can present unique challenges due to their interaction with both DNA and other nuclear proteins.

How does NFYB9 function compare with other NFYB family members in Arabidopsis?

Comparative analysis of NFYB family members reveals distinct functional specializations despite structural similarities:

NFYB MemberMolecular WeightPrimary FunctionsExpression PatternKnown Interactors
NFYB9~23 kDaFlowering regulation, ABA responsesConstitutive, enhanced in reproductive tissuesNFYA2, NFYA7, NFYC2
NFYB7~24 kDaEmbryo development, seed maturationHighest in developing seedsNFYA2, NFYC1
NFYB2~22 kDaPhotomorphogenesis, light signalingLight-responsive tissuesNFYA5, NFYC9
NFYB3~23 kDaDrought stress responsesUpregulated under water stressNFYA1, NFYC3

The functional diversity of NFYB proteins arises from:

  • Differential expression patterns across tissues and developmental stages

  • Selective interaction with specific NFYA and NFYC subunits

  • Post-translational modifications that regulate activity

  • Divergent N-terminal and C-terminal domains that confer specificity

When designing experiments to study NFYB9 function, researchers should employ methodologies that can distinguish between these related family members. This includes using:

  • Gene-specific primers for expression analysis

  • Protein-specific antibodies that target unique epitopes

  • Yeast-two-hybrid or co-immunoprecipitation assays to identify specific interaction partners

  • Chromatin immunoprecipitation followed by sequencing to map binding sites across the genome

Understanding the distinct functions of each NFYB member provides critical context for interpreting experimental results and formulating hypotheses about NFYB9's specific roles.

What methodological approaches are most effective for studying NFYB9's role in plant stress responses?

To comprehensively investigate NFYB9's function in stress responses, implement these methodological approaches:

  • Transcriptional profiling under stress conditions:

    • Perform RNA-seq on wild-type vs. nfyb9 mutant plants under control and stress conditions

    • Use RT-qPCR to validate differential expression of key stress-responsive genes

    • Analyze promoters of differentially expressed genes for CCAAT motifs

  • Chromatin dynamics analysis:

    • Conduct ChIP-seq with NFYB9 antibody under normal and stress conditions

    • Perform ATAC-seq to identify changes in chromatin accessibility

    • Use sequential ChIP to determine if NFYB9 forms different complexes under stress

  • Protein interaction network mapping:

    • Implement IP-MS (immunoprecipitation coupled with mass spectrometry) to identify stress-specific interactors

    • Use bimolecular fluorescence complementation (BiFC) to visualize interactions in planta

    • Perform co-IP with known stress signaling components (e.g., MAPK pathway proteins)

  • Physiological phenotyping:

    • Measure stress tolerance parameters in knockout/overexpression lines

    • Quantify relevant metabolites using GC-MS or LC-MS

    • Analyze hormone levels, particularly ABA, using ELISA or LC-MS/MS

By integrating these approaches, researchers can build a comprehensive model of how NFYB9 functions within stress response networks, potentially revealing novel mechanisms for engineering stress-tolerant crops.

How do I address issues with low signal intensity when using NFYB9 antibody in immunodetection?

When encountering low signal problems with NFYB9 antibody, implement this systematic troubleshooting methodology:

  • Sample preparation optimization:

    • Enrich nuclear proteins using nuclear extraction protocols

    • Use proteasome inhibitors (MG132) during extraction to prevent degradation

    • Consider using a tandem affinity purification approach for enrichment

  • Antibody sensitivity enhancement:

    • Try signal amplification systems like tyramide signal amplification (TSA)

    • Use highly sensitive detection reagents (e.g., SuperSignal West Femto)

    • Consider biotin-streptavidin amplification systems

  • Protocol modifications:

    • Increase antibody concentration incrementally (1:500 to 1:100)

    • Extend primary antibody incubation time (overnight at 4°C to 48 hours)

    • Reduce washing stringency slightly while maintaining specificity

    • Use PVDF membranes with smaller pore size (0.2 μm) to retain small proteins

  • Expression timing considerations:

    • Sample tissues at developmental stages with known higher NFYB9 expression

    • Collect samples during the appropriate diurnal cycle point

This multi-parametric optimization approach addresses the common challenge of detecting nuclear transcription factors like NFYB9 that typically have lower abundance compared to structural or enzymatic proteins.

What strategies can resolve cross-reactivity issues with NFYB9 antibody?

To minimize cross-reactivity with related NFYB proteins, employ these methodological solutions:

  • Epitope-specific approach:

    • Use antibodies raised against unique N-terminal or C-terminal regions of NFYB9

    • Perform peptide pre-absorption controls to confirm specificity

    • Consider using monoclonal antibodies targeting unique epitopes

  • Genetic validation:

    • Include nfyb9 knockout/knockdown mutants as negative controls

    • Use NFYB9-overexpression lines to confirm band identity

    • Implement CRISPR-tagged NFYB9 lines (e.g., with FLAG or HA tags) as references

  • Advanced immunoprecipitation strategies:

    • Perform sequential immunoprecipitation to increase specificity

    • Use stringent washing conditions to remove weak cross-reactive binding

    • Validate results with mass spectrometry identification

  • Computational analysis for antibody design:

    • Utilize epitope prediction algorithms to identify unique NFYB9 regions

    • Design peptide antigens that maximize difference from other NFYB proteins

    • Consider the JAM approach for computational antibody design targeting specific epitopes

Cross-reactivity issues are particularly challenging with the NF-Y family due to the highly conserved histone-fold domain. The methodological solutions above have been developed to address these specific challenges while maintaining experimental rigor.

How are new antibody technologies advancing plant transcription factor research?

Recent technological innovations are transforming antibody-based research for plant transcription factors like NFYB9:

  • Computational antibody design:

    • JAM system enables de novo design of epitope-specific antibodies with nanomolar affinities

    • Computational methods can generate antibodies in both single-domain (VHH) and paired (scFv/mAb) formats

    • These approaches achieve precision epitope targeting without experimental optimization

    • Application to plant research allows for faster development of specific antibodies against transcription factors

  • Nanobody technology adaptation for plant research:

    • Llama-derived nanobodies offer advantages of smaller size and enhanced tissue penetration

    • Their structure allows access to epitopes that conventional antibodies cannot reach

    • The compact size (one-tenth of conventional antibodies) enables better performance in plant tissues

    • Engineering nanobodies in triple tandem format enhances avidity and specificity

  • Enhanced multiplexing capabilities:

    • New multiplex serology techniques enable simultaneous detection of multiple targets

    • GWAS studies incorporating antibody analysis reveal genetic factors affecting immune responses

    • These approaches could be adapted to study plant protein expression networks

    • Multiplexed detection allows for comprehensive analysis of transcription factor complexes

These advanced technologies are particularly valuable for studying plant transcription factors like NFYB9 that function in complex with other proteins and may be present at relatively low abundance in plant tissues.

What role does NFYB9 play in coordinating developmental and stress response pathways?

Emerging research indicates NFYB9 functions as an integrative hub connecting developmental programming with environmental responses:

  • Transcriptional network coordination:

    • NFYB9 binds to CCAAT motifs in promoters of both developmental and stress-responsive genes

    • Forms different heterotrimeric complexes depending on tissue type and environmental conditions

    • Acts as a conditional regulator that can recruit either activating or repressing complexes

  • Integration with hormone signaling:

    • Functions downstream of ABA signaling during stress responses

    • Mediates crosstalk between stress hormones and flowering pathways

    • Modulates sensitivity to growth hormones under stress conditions

  • Epigenetic regulation mechanisms:

    • The histone-fold domain of NFYB9 enables interaction with chromatin modifiers

    • Facilitates changes in histone modifications at target loci

    • Contributes to stress memory through persistent chromatin changes

  • Developmental phenotypes of nfyb9 mutants:

    • Primary phenotypes include altered flowering time and reduced fertility

    • Secondary phenotypes emerge under stress conditions, including compromised drought tolerance

    • Overexpression lines show enhanced stress resilience but developmental abnormalities

This integrative function positions NFYB9 as a potential target for engineering plants with improved stress tolerance without compromising normal development. Research methodologies should focus on systems biology approaches that can capture these multifaceted roles across developmental stages and stress conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.